Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome

1. Schramm, A.
2. Schowe, B.
3. Fielitz, K.
4. Heilmann, M.
5. Martin, M.
6. Marschall, T.
7. Köster, J.
8. Vandesompele, J.
9. Vermeulen, J.
10. De Preter, K.
11. Koster, J.
12. Versteeg, R.
13. Noguera, R.
14. Speleman, F.
15. Rahmann, S.
16. Eggert, A.
17. Morik, K.
18. Schulte, J.H.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1038/BJC.2012.391 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus